Annual income of 25 million! MiTi: Many companies compete for the naming rights of the new San Siro, with a valuation of 25 million

Football     11:35pm, 9 November 2025

Previously, the Milan duo officially announced that they have officially acquired the San Siro/Meazza Stadium and will design and build a new stadium. According to the Italian media "Gazzetta dello Sport", many companies are now interested in the naming rights of the new stadium, and it is expected that the Milan duo will receive 25 million euros in revenue each year.

According to reports, the Milan duo are expected to receive substantial income from the new stadium. Among the core income channels, naming rights are particularly prominent. In layman's terms, it means which company can have its name appear on the facade of the new San Siro Stadium to showcase its brand to the world.

At present, the work of selecting a stadium naming partner is still in the early stages, and it only remains at the level of expressing cooperation intentions and making preliminary contacts to assess the feasibility of cooperation. But at present, there are many potential candidates on the list. One of them is Generali Groupe. Italy's largest insurance company has historically shown a strong interest in the sports field and its brand image is considered very suitable in the current market environment.

Although it is difficult to accurately estimate the specific amount of this transaction, there are preliminary expectations. Juventus signed a ten-year cooperation agreement with the Allianz Group in 2020, totaling 103 million euros, including a variety of sponsorship forms, of which the naming rights part is valued at 7 million to 10 million euros per year.

The Milan duo can provide a more attractive display platform and double exposure. Both teams are championship contenders in the league and various cups. Therefore, although it is still in the early stages, the asking price of both parties has reached 25 million or even 30 million euros per year.

Mini-game recommendations:Bloxorz